Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 197

1.

Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance.

Mason MD, Moore R, Jones G, Lewis G, Donovan JL, Neal DE, Hamdy FC, Lane JA, Staffurth JN; ProtecT Study Group..

Clin Oncol (R Coll Radiol). 2016 Sep;28(9):e92-e100. doi: 10.1016/j.clon.2016.05.011.

PMID:
27425582
2.

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.

Lane A, Metcalfe C, Young GJ, Peters TJ, Blazeby J, Avery KN, Dedman D, Down L, Mason MD, Neal DE, Hamdy FC, Donovan JL; ProtecT Study group..

BJU Int. 2016 Dec;118(6):869-879. doi: 10.1111/bju.13582.

3.

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.

Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K; UK Genetic Prostate Cancer Study Collaborators.; UK ProtecT Study Collaborators.; PRACTICAL Consortium., Easton DF, Eeles RA, Kote-Jarai Z.

Br J Cancer. 2016 Apr 12;114(8):945-52.

PMID:
26964030
4.

Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy.

Engelstad K, Sklerov M, Kriger J, Sanford A, Grier J, Ash D, Egli D, DiMauro S, Thompson JL, Sauer MV, Hirano M.

Hum Reprod. 2016 May;31(5):1058-65. doi: 10.1093/humrep/dew033.

PMID:
26936885
5.

Recovery-based services in a psychiatric intensive care unit - the consumer perspective.

Ash D, Suetani S, Nair J, Halpin M.

Australas Psychiatry. 2015 Oct;23(5):524-7. doi: 10.1177/1039856215593397.

PMID:
26148737
6.

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.

Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, Aly M, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, Mcdonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokołorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Arndt V, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Govindasami K, Guy M, Lophatonanon A, Muir K, Viñuela A, Brown AA; PRACTICAL Consortium.; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative.; Australian Prostate Cancer BioResource.; UK Genetic Prostate Cancer Study Collaborators.; UK ProtecT Study Collaborators., Freedman M, Conti DV, Easton D, Coetzee GA, Eeles RA, Kote-Jarai Z.

Hum Mol Genet. 2015 Oct 1;24(19):5589-602. doi: 10.1093/hmg/ddv203.

7.

Nitric oxide is the key mediator of death induced by fisetin in human acute monocytic leukemia cells.

Ash D, Subramanian M, Surolia A, Shaha C.

Am J Cancer Res. 2015 Jan 15;5(2):481-97.

8.

Five-year review of absconding in three acute psychiatric inpatient wards in Australia.

Gerace A, Oster C, Mosel K, O'Kane D, Ash D, Muir-Cochrane E.

Int J Ment Health Nurs. 2015 Feb;24(1):28-37. doi: 10.1111/inm.12100.

PMID:
25444670
9.

Beclin-1-p53 interaction is crucial for cell fate determination in embryonal carcinoma cells.

Tripathi R, Ash D, Shaha C.

J Cell Mol Med. 2014 Nov;18(11):2275-86. doi: 10.1111/jcmm.12386.

10.

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.

Lane JA, Donovan JL, Davis M, Walsh E, Dedman D, Down L, Turner EL, Mason MD, Metcalfe C, Peters TJ, Martin RM, Neal DE, Hamdy FC; ProtecT study group..

Lancet Oncol. 2014 Sep;15(10):1109-18. doi: 10.1016/S1470-2045(14)70361-4. Erratum in: Lancet Oncol. 2014 Oct;15(11):e475.

11.

Slow and sustained nitric oxide releasing compounds inhibit multipotent vascular stem cell proliferation and differentiation without causing cell death.

Curtis BM, Leix KA, Ji Y, Glaves RS, Ash DE, Mohanty DK.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):208-12. doi: 10.1016/j.bbrc.2014.05.087.

12.

Electroconvulsive therapy for the neurological and psychiatric manifestations of multiple system atrophy.

Chia N, Kimber T, Ash D.

Aust N Z J Psychiatry. 2014 Sep;48(9):877. doi: 10.1177/0004867414525864. No abstract available.

PMID:
24567540
13.

Early recognition of anti-N-methyl D-aspartate (NMDA) receptor encephalitis presenting as acute psychosis.

Tidswell J, Kleinig T, Ash D, Thompson P, Galletly C.

Australas Psychiatry. 2013 Dec;21(6):596-9. doi: 10.1177/1039856213506502.

PMID:
24108083
15.

A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy.

Ash DB, Papadimitriou D, Hays AP, Dimauro S, Hirano M.

Arch Neurol. 2012 Sep;69(9):1190-2. doi: 10.1001/archneurol.2011.2600.

16.

Metabolic health of people admitted to a psychiatric intensive care unit in adelaide, South australia.

Ash D, Singh T, Air T, Burton C, Galletly C.

Prim Care Companion CNS Disord. 2012;14(1). pii: PCC.11l01207. doi: 10.4088/PCC.11l01207. No abstract available.

17.

Feasibility of using flash-heated breastmilk as an infant feeding option for HIV-exposed, uninfected infants after 6 months of age in urban Tanzania.

Chantry CJ, Young SL, Rennie W, Ngonyani M, Mashio C, Israel-Ballard K, Peerson J, Nyambo M, Matee M, Ash D, Dewey K, Koniz-Booher P.

J Acquir Immune Defic Syndr. 2012 May 1;60(1):43-50. doi: 10.1097/QAI.0b013e31824fc06e.

18.

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group., Li J.

Ophthalmology. 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014.

PMID:
21764136
19.

Cysteine 351 is an essential nucleophile in catalysis by Porphyromonas gingivalis peptidylarginine deiminase.

Rodríguez SB, Stitt BL, Ash DE.

Arch Biochem Biophys. 2010 Dec 15;504(2):190-6. doi: 10.1016/j.abb.2010.09.008.

20.

Infant feeding practices among HIV-positive women in Dar es Salaam, Tanzania, indicate a need for more intensive infant feeding counselling.

Young SL, Israel-Ballard KA, Dantzer EA, Ngonyani MM, Nyambo MT, Ash DM, Chantry CJ.

Public Health Nutr. 2010 Dec;13(12):2027-33. doi: 10.1017/S1368980010001539.

Items per page

Supplemental Content

Loading ...
Support Center